chrisvoncsefalvay/vaers-outcomes huggingface dataset:
positive for Covid/ symptoms of Covid; positive for Covid/ symptoms of Covid; This is a spontaneous report from a contactable nurse (reported for himself). A 33-year-old male patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, lot/batch number and expiration date not provided), via an unspecified route of administration on 17Dec2020 at single dose for COVID-19 immunization. The patient's medical history and concomitant medications were not reported. Patient got the first dose of the vaccine on 17Dec2020 and then around Christmas he developed symptoms of Covid (Dec2020). On 27Dec2020, he came back positive for Covid and wanted to know if he skip the second dose. Patient questioned what percentage of persons obtained immunity after the first product dose. The outcome of the events was unknown.  Information on the lot/batch number has been requested.; Sender's Comments: Based on the information currently available, a lack of efficacy with the suspected vaccine BNT162B2 in this patient cannot be completely excluded.  Further information like confirmative virus genome /nucleic acid detection is needed for meaningful medical assessment.
With dried up dark red papules 3 on the right shoulder. On the right upper back; with sore red crusted one on her upper and lower extremities, one crusted on the suprapubic area; with a new red papule on the dorsum of right hand; also with red excoriated to crushing macropapular rashes on her left lumbar area.
12JUL91 pt recd vax; 4wks later, devel salmonellosis; 20AUG91 recovered from salmonellosis; fever persisted; 26AUG91 devel papular exanthema, lymphadenitis & anicteric hepatitis; Gianotti-Crosti syndrome suspected; MD felt poss R/T vax;
April 15, 2021 Patient  Moderna  Vaccine  NDC#  80777-273-99   Lot # 003B21A   Left Deltoid   Episode following Second Moderna vaccination.  1:15   Injection received 1:30   Exited facility to vehicle 1:40   Returned to facility accompanied by her husband and stated she was having some involuntary ?jerky? movements stating that she has a history of Psychogenic Movement Disorder. Medical diagnosis was not provided until 25 minutes post vaccination.  VS:  B/P   140/80   HR  69   O2 Sat 98%   R 20 1:48   EMS notified. Patients son-in-law is a physician  and was contacted by patient.  He is aware of her history and advised that he would call her family physician and have medication available for her. 1:52   EMS request was cancelled at the request of the patient.  Husband was to transport patient to facility for treatment. 2:00   Patient to vehicle via wheelchair by RN.  No signs or symptoms of distress noted.  VAERS and ARIA filed  5:15   Follow-up phone call to patient.  She was given a prescription medication, she was unable to remember the name of the medication, to ?reset? or ?relax? her spasms.  They had improved but not completely gone.  Will recheck with patient tomorrow.  April 16, 2021  9:45 a.m.  Follow-up phone call to patient. She is still having spasms.  They are slowly improving but still not back to her baseline. Advised patient to follow-up with her family physician if symptoms do not continue to improve.
Diarrhea and lightheadedness apprx. 2 hrs after injection. Sx continued until next day. HA experienced on 08/17-08/18/02.
large palm-sized red, swollen area at injection site.  This area is very hard and warm-hot to the touch.  It increased in diameter from Tuesday morning through Weds. night.  Today, Thursday site is red, hot, itchy with swelling noticeable under clothing.   Tylenol helps with general soreness of area.  Using topical steroid to help with itching, no improvement with that.
Information has been received from a physician and a practice manager referring to a patient of unknown age and gender. On 31-AUG-2015, the patient was vaccinated with an improperly stored dose of GARDASIL (lot # K014191, expiration date 21-MAY-2017). This specified lot number vaccine was exposed to temperature excursion once. The total cumulative excursion time of the first time was 32 hours with the lowest recorded temperature of 34 Fahrenheit degree (the highest temperature was not reported). The storage criteria and the type of excursion for this vaccine was refrigerator (R). This is one of several reports received from the same source. Additional information has been requested.
11:00 Shingrix given. By 4;30 the same day first hit with diarrhea than 15 minutes later hit with vomitting and than 15-20 minutes diarrhea again.  After that very tired and left arm sore.  Hard time sleeping because arm was sore.
RN  administering dose when needle came off syringe-needle was not tightly attached to syringe. Only 0.25mL of medication (Jansen vaccine) administered. Provider notified and consulted with patient at chairside. Pt agreed to have another injection of remaining 0.25mL per provider recommendation for a total dose of 0.5ml for optimal protection against COVID19.
I received my 2nd booster shot on 04/20/2022 and my adverse event started on the same day at around 8:15PM CT. 04/22/2022 I saw swelling on the right lower leg. 04/23/2022 the swelling progressed on both the legs and it got worst over the weekend. 04/24/2022- swelling progressed. On 04/25/2022 I went to see my family doc she said I should go to the emergency room to see if I have DVT. 04/26/2022-04/28/2022 swelling progressed. 04/28/2022 I went back to the emergency room. This time the ultrasound was correct for DVT on the right leg. Then they sent me home without no treatment because the doctor said it was non- exclusive DVT which did not needed treatment. 04/30/2022- I had  numbness on my left leg because I had DVT I thought I was having heart attack or stroke so I went back to the emergency room. At that time they determined that nothing happened. They couldn't find out exactly what was wrong with me. They admitted me on observation so I can have a stress test on the first thing in the morning on May 2, 2022. I passed the stressed test and I was discharged on Eliquis. I still have the hot flashes, fever, arm exhausted, I am tired,  fatigue, no energy.  I  went to so many specialists like rheumatologists, GI, urology, dermatologist, and counting. No one was able to rule out what was happening to me or what I have. All this happened after my 2nd booster shot.
This case was reported by a consumer via call center representative and described the occurrence of headache in a 65-year-old female patient who received SHINGRIX for prophylaxis. Concomitant products included SHINGRIX. On 28th July 2018, the patient received the 2nd dose of SHINGRIX (intramuscular) .5 ml. In July 2018, less than a day after receiving SHINGRIX, the patient experienced headache, fatigue, fever and nausea. On an unknown date, the outcome of the headache, fatigue, fever and nausea were recovered/resolved. It was unknown if the reporter considered the headache, fatigue, fever and nausea to be related to SHINGRIX. Additional details reported as follows: This case was not reported to anyone previously. On 4th May 2018, the patient received the 1st dose of SHINGRIX. The reporter woke up the next morning after receiving the SHINGRIX vaccine on left arm with the following symptoms, bad headache, a little bit of nausea, fatigue, and a fever of 100.9 degree F as of mid morning. The symptoms resolved within 36 hours. This case has been linked with US2018136246, reported by same reporter.
(R) neck pain 5 days after Varivax booster. Vesicular eruption (R) neck and (R) chin 1 wk after Varivax.
This case was reported by a healthcare professional and described the occurrence of injection site reaction in a 51-year-old female subject who was vaccinated with ENGERIX B (GlaxoSmithKline). Concurrent medical conditions included allergic to compazine, allergy to LORTAB, allergy to oxycodone, allergy to sulfa drugs, depression, diabetes, emphysema, hepatic encephalopathy, hypertension, nausea, non alcoholic steatohepatitis, penicillin allergy and vomiting. Concurrent medications included Aspirin, Glipizide, Hyoscyamine, IRON, KLONOPIN, Lactose, ONDANSETRON, PHENERGAN, PREMARIN, PROBIOTIC, PROTONIX, PROVENTIL, PROZAC, SINGULAIR, Stool softener, Vitamin E and XIFAXAN. On 23 July 2012 at 16:00 the subject received 3rd dose of ENGERIX B (20 mcg, intramuscular, right deltoid). On 24 July 2012, 1 day after vaccination with ENGERIX B, the subject experienced a larger than expected injection site reaction, injection site redness, swelling injection site and injection site tingling. The subject was recommended an unknown (Over counter medicines) for treatment by the healthcare professional. At the time of reporting the larger than expected injection site reaction, injection site redness, swelling injection site and injection site tingling were unresolved. The healthcare professional considered the events were probably related to vaccinations with ENGERIX B.
Menveo expired and was administered; This case was reported by a other health professional via call center representative and described the occurrence of expired vaccine used in a patient who received Men ACWY-CRM NVS (Menveo) (batch number AMVA431A, expiry date 20th October 2021) for prophylaxis.   On 3rd January 2022, the patient received Menveo. On 3rd January 2022, unknown after receiving Menveo, the patient experienced expired vaccine used. On an unknown date, the outcome of the expired vaccine used was unknown.  Additional details were provided as follows: The age at vaccination was not reported. The patient received expired dose of menveo, which led to expired vaccine used. No reactions reported. The reporter consented to follow up.
pain & weakness, +swelling of lt arm, problems persisted until tx w/immunobiosis tx as per MD;skin test for egg was negative;treated 6NOV98;
Headache; Dizziness; Muscle twitching; This is a spontaneous report from a contactable consumer, the patient. A 63-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EN6199) via an unspecified route of administration in the left arm on 12Mar2021 at 14:30 (at the age of 63-years-old) as a single dose for COVID-19 immunisation. Medical history included high cholesterol, high blood pressure; both controlled. The patient had known allergies to an unspecified antibiotic but could not remember the name and had not taken for years. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN), rosuvastatin calcium (CRESTOR), vitamin d nos (MANUFACTURER UNKNOWN) and "daily multi"; all taken for unknown indications from an unknown date and unknown if ongoing. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. On 14Mar2021, 2 days after vaccine, the patient experienced headache, dizziness, muscle twitching. She was now (at the time of this report) 6 weeks out and still had some dizziness and sometimes a headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events headache, dizziness and muscle twitching were not recovered at the time of this report.  No follow-up attempts are needed. No further information is expected.
Local well circumscribed area, 2 cm of erythema, tenderness, swelling left deltoid. Positive systemic malaise post 3rd vax Hep-b.
Rash and hives on back, and arm.    TRIAMCINOLONE 0.1% CREAM  2X A DAY.  Rash/Hives/itching improved after several days
fever, swelling of leg, fussy, redness on leg. We believe it was the HIB vaccine.
over 24 hour injection site swelling occurred with spread of rash across chest toward back and toward forearm. treated 4 days later in ED with benadryl and steroids with immediate improvement.
States abdomen feels fuller than usual below solar plexus and feels like invading lung space. States feels like it is strenuous to climb steps when normally no problem. States feels like might be coming down with illness. States her limbs feel heavy. Easily fatigued, hard to breathe sometimes. Small pinpoint red spots on legs ? petechiae (normal platelet count).
pt recvd vax; approx 3 hrs later, rt thigh became "beet" red,very warm to touch;extremely fussy;apap given prior to vax;advised to use cool cloth & cont apap;low grade fever;to MD who felt no specific rx indicated;
Toe area only on the feet hurt- no swelling; right hand- all her knuckles are hurting and swollen; Muscles in her arms and legs are hurting- feels like she has been working out with weights; has no strength in her right hand; right hand- all her knuckles are hurting and swollen; an increase of a flair up of arthritis; swelling in her feet; sleepy; feeling tired; This is a spontaneous report from a contactable consumer (patient). A 65-years-old female patient received second dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot Number and Expiration Date: unknown), via an unknown route of administration on 02May2021 (at the age of 65-years-old) as dose 2, single for covid-19 immunization. Medical history included arthritis from an unknown date and unknown if ongoing. The patient's concomitant medications were not reported. The patient previously took first dose of bnt162b2 on an unknown date as dose 1, single for covid-19 immunization. On an unknown date in May2021, she was complaining of an increase of a flair up of arthritis and swelling in her feet, feeling tired and sleepy the second day after the vaccine. She began having the following symptoms around the 09May2021, toe area only on the feet hurt- no swelling; right hand- all her knuckles are hurting and swollen; Muscles in her arms and legs are hurting- feels like she has been working out with weights; ripping boxes open at work is difficult, almost like she has no strength in her right hand. On 09May2021, she started feeling joint pains and her muscles hurt like she had been exercising, but she was not exercising. In the past she had arthritis in her left hand and now she has that arthritis pain in all joints and in both hands and feet. It was like her arthritis is flaring up. The first week the arthritis pains would come and go, but since last Monday it has been ongoing non-stop. The arthritis has flared up in other locations other than her left hand, again mentions she only had it in her left hand. Now she has it the right hand and in both in feet and they are swelling. Outcome of events increase of a flair up of arthritis, toe area only on the feet hurt- no swelling and right hand- all her knuckles are hurting and swollen was not resolved while the outcome of other events was unknown.   No follow-up attempts are needed; information about lot/batch number cannot be obtained.
This spontaneous report was received from a medical assistant regarding herself, a female patient of unknown age. The patient had no concomitant medications, medical history, concurrent conditions and no drug reactions/allergies. On 21-MAY-2018, the medical assistant was drawing up a dose of GARDASIL 9, (lot # N025428 with an expiration date in 19-JUN-2020), for prophylaxis, that was supposed to be administered to a patient, and an unknown amount splashed into her eye, and since then, "her eye felt funny" (abnormal sensation in eye), the reporter was not able to clarify further. Moreover, it was also reported that the patient sough medical attention via telephone call, but no treatment was prescribed for the patient. At the time of reporting, the outcome of abnormal sensation in eye was reported as not recovered. The causal relationship between GARDASIL 9 and the abnormal sensation in eye was not provided.
Toes swollen; painful feet; itchy; red on bilateral feet; This is a spontaneous report from a contactable other healthcare professional (patient herself). A 33-year-old non-pregnant female patient received first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, Formulation: Solution for injection, Lot number: EN53.8), via an unspecified route of administration in left arm on 23Jan2021 12:30 at single dose for Covid-19 immunization in facility type of other. The patient's medical history included dysthymia, and there was no allergies to medications, food, or other products. Patient did not have any allergies to medications, food, or other products. Concomitant medication included bupropion within 2 weeks of vaccination in 2021. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient wasn't diagnosed with COVID-19. Since the vaccination, the patient hadn't been tested for COVID-19. The patient experienced toes swollen, painful feet, itchy, red on bilateral feet on 26Jan2021 08:00. There was not treatment received for the adverse events. The events were considered as non-serious by the other healthcare professional. The outcome of the events was not recovered.
25 minutes post Covid-19 vaccine, patient reported feeling "itchy."  Red rash noted to neck, chest and bilateral arms. Patient given IM Benadryl.  Within 2 minutes, patient reported less "itchy" feeling.  At 1550 patient reported no further "itchy" feeling.  Patient denies any other issues.  Patient sitting on stretcher talking with pharmacist.  Patient reports full relief.  No issues voiced.  Patient educated to speak with her PCP prior to 2nd dose of Covid-19 vaccine and to report today's reaction to PCP.  Patient states understanding of the above.
Client reported abdominal discomfort 10 minutes after vaccination.  Stated, "I think that my sugar is low."  Blood sugar 114.  Complained of feeling hot and cold.  Exited car and spat out clear secretions.  Client observed for 30 minutes.  Reported that abdominal discomfort felt "A little better." Declined further observation.  Driven off site by her son.
A report has been received from a health professing concerning a subject of unknown gender, who had been receiving FLUMIST. FLUMIST started on an unknown date. The patient experienced fever. The outcome of the event of fever is unknown. The report was considered to be non-serious by the reporter.
Next day (10/9/15) pin prick rash stomach and back, no itching. Didn't feel well over weekend. Headache this AM now nauseated ?fever (didn't know).
Rcv'd vax and was very fussy dring night. Had vomiting episodes next day. Could not rule out superimposed viral illness w/ possible rxn to vax, D/T red/warm/knot at that vaccine site.
The patient presented to the Health Department's COVID-10 Moderna booster vaccine clinic for a booster dose of Moderna. The patient provided a vaccination card which was reviewed and only reflected that he had previously received 1 dose of the Johnson & Johnson COVID vaccine. The patient also responded verbally to received 1 dose of the Johnson & Johnson vaccine. The Moderna booster vaccine was administered and the patient was monitored for 15 minutes post-vaccination with no adverse effects. Upon entering the administration into the system, it was noted that the patient had received a dose of Pfizer vaccine on 7/19/21 at Pharmacy which had not been reflected on the card that was reviewed nor verbally communicated by the patient. Attempts to contact the patient by telephone were made following this discovery and phone calls were not returned. As a result, it is suspected that the patient received an initial dose of Johnson & Johnson on 4/5/21; a booster dose of Pfizer on 7/19/21; and a booster dose of Moderna on 1/6/22 per the system records.
Wasn't feeling great/felt awful; Had a headache/headaches for the past 2-3 weeks and everyday since/keeps waking up with a headache everyday; Mostly tired; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION COMPLICATION, HEADACHE, and FATIGUE in a 73-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 071F21A, 029L20A, and 013B20A) for COVID-19 vaccination.     No Medical History information was reported.   On 12-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 10-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Oct-2021, received third dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 23-Oct-2021, the patient experienced VACCINATION COMPLICATION, HEADACHE, and FATIGUE. The patient was treated with TYLENOL for Adverse event, at an unspecified dose and frequency and ADVIL for Adverse event, at an unspecified dose and frequency. At the time of the report, VACCINATION COMPLICATION, HEADACHE, and FATIGUE outcome was unknown.            No Concomitant medications were provided by the reporter.    23OCT2021, Patient undergone for ultrasound of brain and waiting for neurologist appointment.   This case was linked to MOD-2021-380630 (Patient Link).
This spontaneous report as received from a certified medical assistant refers to a patient of unknown demographics. On an unknown date, the patient was vaccinated with a dose of improperly stored GARDASIL (Lot number, expiry date, route and dose were not reported). The certified medical assistant reported that the vaccine was exposed to temperature of 26 F(Fahrenheit)for a total of 135 hours. No adverse effects reported. Follow-up received. Certified Medical assistant stated that other 104 children received GARDASIL. Follow up information has been received from the certified medical assistant regarding a 17years old, male patient with no pertinent medical history reported. On 21-NOV-2012 the patient was vaccinated with the first dose of GARDASIL (lot number and expiration date not reported) (intramuscular on the right arm, dose not reported). It was reported that the patient did not seek medical attention. This is one of the several reports from the same source. Additional information is not expected.
3 1/2 weeks after immunization Pt hand and feet became numb and tingling. The numbness went to his legs and body and he was unable to stand. On 6/26/04 he went to the ER  and they misdiagnosed him. He returned to hospital on 6/29/04 and was diagnosed with Guillian Barre Syndrome. He was treated with 5 blast IV CG Antibody.
Myalgia, Fever,  INJECTION SITE PAIN, FEVER, MUSCLE ACHES, JOINT PAIN, FEVER  Narrative:
3hrs after vaccine pt had bright red blood and mucus in stool. Up to 10-14 stools on days 1-3, then 5 stools with mucus, then 2-3 stools with mucus for 3days. 1hr of crying in the middle of the night after vaccine, went to ER.
WARM; SWEATING (ON THE SECOND DAY); SORE ARM THE FIRST DAY AFTER THE SHOT; This spontaneous report received from a consumer concerned an 18 year old female. The patient's height, and weight were not reported. No past medical history or concurrent conditions were reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: Unknown) dose was not reported, administered on APR-2021 for prophylactic vaccination. The batch number was not reported. Per procedure, no follow-up will be requested for this case. No concomitant medications were reported.  On APR-2021, the patient experienced warm. On APR-2021, the patient experienced sweating (on the second day). On APR-2021, the patient experienced sore arm the first day after the shot. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The outcome of the sore arm the first day after the shot, warm and sweating (on the second day) was not reported. This report was non-serious.